About: Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2008 (uk) artículu científicu espublizáu en xunetu de 2008 (ast) scientific article published on 01 July 2008 (en)
publication date	wds:Q81644055-3191A92E-1553-4B2B-A4E1-D6F77E799021
publication date	2008-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q81644055-13A27C14-067B-477B-8451-8BB182D65621 wds:Q81644055-156667A4-DD22-4E8B-ACE9-B1FD9771425A wds:Q81644055-16A30D4C-2BD4-4519-8890-111E72203C6E wds:Q81644055-186D1402-D18F-4D6E-9FBE-F755277D7CDB wds:Q81644055-2413A124-EF7A-4D09-8B2F-E54BAF8FF6FA wds:Q81644055-311737FD-D80E-4A72-9982-346ACCB929EC wds:Q81644055-35DCF6FB-D23F-4892-8198-8878E448A799 wds:Q81644055-9FEAD131-F978-4247-A06B-3AF80CAA45F4 wds:Q81644055-AF129668-16CD-45CD-9371-BE77E51AD7D5
author name string	Rik J Scheper Paul A M van Leeuwen Alfons J M van den Eertwegh Sybren Meijer Saskia J A M Santegoets John B A G Haanen Pepijn G J T B Wijnands Barbara G Molenkamp Berbel J R Sluijter
rdfs:label	Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (en) Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (nl)
skos:prefLabel	Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (en) Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (nl)
name	Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (en) Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (nl)
author	wds:Q81644055-BCB3BE8D-BA31-408D-9FE7-ED2D8E36973C
author	Tanja D de Gruijl
title	wds:Q81644055-076DB5D9-DFCB-496F-BA30-7D9251C65601
title	Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients (en)
page(s)	wds:Q81644055-C40A7C4F-767C-4965-A663-2E09BF56406A
page(s)	4532-4542
instance of	wds:Q81644055-BD9B3E61-365C-45C0-B376-DC88A9F1CE95
instance of	scholarly article
PubMed ID	wds:Q81644055-16B26C60-4BB8-4258-8AFE-BD467D2C2171
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18628468
PubMed ID	18628468
published in	wds:Q81644055-10E7C7D3-AE14-4B6D-A007-153C4BDA10DE
published in	Clinical Cancer Research
issue	wds:Q81644055-A8E81ADF-23F1-4FE4-A536-DF0C12F9D4A2
volume	wds:Q81644055-865517C1-CE78-4995-8BBA-CE917550A00D
issue	14
volume	14
DOI	wds:Q81644055-53AA3C59-536F-42D0-A0D3-0D9D93FFB13E
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-07-4711
DOI	10.1158/1078-0432.CCR-07-4711
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81644055
is cites work of	Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice Targeting the tumor microenvironment to enhance antitumor immune responses Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node HMGB1 mediates endogenous TLR2 activation and brain tumor regression In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells Tumor evasion from T cell surveillance Recent progress concerning CpG DNA and its use as a vaccine adjuvant Toll-like receptor agonists in cancer therapy A novel cancer vaccine strategy based on HLA-A0201 matched allogeneic plasmacytoid dendritic cells Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor Immunotherapy for melanoma: current status and perspectives CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic Trial Watch: Experimental Toll-like receptor agonists for cancer therapy A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine. Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909. Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. Effect of CpG ODN on monocytic myeloid derived suppressor cells Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and Suppression Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models RNA vaccines in cancer treatment CpG Oligonucleotides as Cancer Vaccine Adjuvants Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates Oligodeoxynucleotides expressing polyguanosine motifs promote antitumor activity through the upregulation of IL-2. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways. Unlocking the therapeutic potential of primary tumor-draining lymph nodes TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes Prospect of Plasmacytoid Dendritic Cells in Enhancing Anti-Tumor Immunity of Oncolytic Herpes Viruses TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis In vivo cancer vaccination: Which dendritic cells to target and how? Dendritic cells in cancer immunology and immunotherapy Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes Toll-like receptors and cutaneous melanoma HLA-A()0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients. Toll-Like Receptor 9 Agonists for Cancer Therapy. A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia 'DURVIT': a phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: safety, toxicity and effect on the primary tumour- and lymph node microenvironment Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis
is cites work of	wds:Q33573323-EE0591ED-A9A8-4EC5-AC54-903902EAE47C wds:Q36453216-D6C1BEAF-A4C6-466C-A7A8-C3DCCAAEAFB9

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software